Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

<p>Genomic features of patients with long-term response (LTR) compared to non-LTR and progressive disease (PD).</p>

Spremljeno u:

Bibliografski detalji
Glavni autor:	Rohit Thummalapalli (17314483) (author)
Daljnji autori:	Biagio Ricciuti (14951247) (author), Chaitanya Bandlamudi (15047205) (author), Daniel Muldoon (17314486) (author), Hira Rizvi (16547594) (author), Arielle Elkrief (15055750) (author), Jia Luo (15034764) (author), Joao V. Alessi (17314489) (author), Federica Pecci (15561470) (author), Giuseppe Lamberti (15024714) (author), Alessandro Di Federico (15561473) (author), Lingzhi Hong (17314492) (author), Jianjun Zhang (16041833) (author), John V. Heymach (14934698) (author), Don L. Gibbons (15055721) (author), Andrew J. Plodkowski (15028415) (author), Vignesh Ravichandran (15052350) (author), Mark T.A. Donoghue (15054209) (author), Chad Vanderbilt (15050973) (author), Marc Ladanyi (15050661) (author), Charles M. Rudin (11572933) (author), Mark G. Kris (15055774) (author), Gregory J. Riely (14961725) (author), Jamie E. Chaft (14937195) (author), Matthew D. Hellmann (14937198) (author), Natalie I. Vokes (17314495) (author), Mark M. Awad (14961722) (author), Adam J. Schoenfeld (15022025) (author)
Izdano:	2025
Teme:	Cancer Cancer Detection and Diagnosis Immuno-oncology Clinical Research and Trials Biomarkers Prognostic biomarkers Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Lung Cancer Precision Medicine
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti